Glenmark Pharmaceuticals introduces Latanoprost Ophthalmic Solution in the U.S.
Inc., USA has launched the Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL), a product that is bioequivalent and ...
Le Lézard19h
Clear Channel Outdoor Holdings, Inc. to Participate in J.P. Morgan's 2025 Global Leveraged Finance Conference
Clear Channel Outdoor Holdings, Inc., (NYSE:CCO) announced today that Scott Wells, Chief Executive Officer of Clear Channel ...
Le Lézard19h
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
Theratechnologies Inc. ("Theratechnologies" or the "Company") , a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine ...
Daily23h
Glenmark Rolls Out Generic Xalatan in US, Targets USD 113M Market
New Delhi: Glenmark Pharmaceuticals on Friday said its subsidiary has launched generic medication to treat glaucoma in the US ...
MT Newswires on MSN20h
Indian Equities Extend Losses on Trump's Reciprocal Tariffs Threat
Indian equity markets closed lower for the eighth consecutive session on Friday, weighed down by new tariff threats from the US. US President Donald Trump vowed to impose reciprocal tariffs on every ...